Check out the companies making headlines in premarket trading. Bristol-Myers Squibb — The biopharmaceutical stock jumped 5.3% after the Food and Drug Administration approved Cobenfy as a treatment of schizophrenia for adults. It marks the first new type of treatment for the mental disorder in several decades. Novo Nordisk – U.S.-listed shares of the Danish health care company slid 2.9% after JPMorgan said to expect a lower sales figure than Wall Street expects for the third quarter.
This comes after Hindenburg Research revealed it had taken a short position in the company last month, listing "fresh evidence of accounting manipulation" as a reason. Cassava Sciences — Shares tumbled 11.5% after the biotech company settled a case with the Securities and Exchange Commission over "misleading claims" regarding an Alzheimer's clinical trial. Cassava Sciences agreed to pay civil penalties of $40 million dollars.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
La source: AP - 🏆 728. / 51 Lire la suite »
La source: ksatnews - 🏆 442. / 53 Lire la suite »
La source: wjxt4 - 🏆 246. / 63 Lire la suite »